Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210028078 210022584 null 27.8 Curative (C) 2017-10-30 2017-11-07 CARBOPLATIN + LOMUSTINE + VINCRISTINE 02 N 210025000 UKALL 60+ TRIAL
210028079 210013750 1.52 49.7 Disease modification (D) 2016-08-04 2016-09-08 CYTARABINE + ETOPOSIDE N N 210025389 CLL210 TRIAL
210028080 210028171 1.74 66 Disease modification (D) null 2019-10-25 CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE 02 N 210025456 ALL MAINTENANCE
210028081 210013752 1.82 46.3 Palliative (P) 2020-03-19 2020-03-19 PACLITAXEL N N 210025572 ALL MAINTENANCE
210028082 210013754 1.78 49 null null 2016-12-26 Bortezomib + MELPHALAN Y N 210025600 OFATUMUMAB
210028083 210013754 1.71 45.3 null 2015-06-22 2015-06-22 CLL210 TRIAL N N 210025600 ALEMTUZUMAB + CYCLO + FLUDARABINE
210028084 210013755 1.63 78.9 Curative (C) 2017-03-17 2017-03-17 Alemtuzumab + Cyclophos TBI Allo N Y 210025657 DAUNORUBICIN
210028085 210013756 1.59 79.4 null 2019-01-04 2019-01-04 CYCLET N N 210025797 TAMIGA TRIAL
210028086 210022592 1.75 null Curative (C) 2017-04-18 2017-05-21 CNS LGG Irinotecan & Bevacizumab N N 210025907 FLUOROURACIL
210028087 210033700 1.61 49.7 Disease modification (D) 2016-12-09 2016-12-10 CLL210 TRIAL N N 210025962 CYTARABINE INTRATHECAL
210028088 210013760 null null Disease modification (D) 2017-07-03 2017-07-06 CYCLET N N 210026481 DABRAFENIB + TRAMETINIB
210028089 210022594 1.71 64.4 Curative (C) 2018-03-07 2018-04-11 PACLITAXEL 02 N 210026609 NILOTINIB
210028090 210013762 1.65 83.8 Disease modification (D) 2013-04-07 2013-08-26 PACLITAXEL N N 210026763 IDARUBICIN
210028091 210022597 1.79 null null 2017-01-11 2017-02-26 ICE-R (Cycle 1) N N 210027544 BEAM
210028092 210028177 0 112.8 Disease modification (D) 2015-10-27 2015-11-09 Irinotecan + Modified De Gramont N N 210027549 SIOP
210028093 210013768 1.42 59.2 Not known (9) 2014-02-21 2014-09-09 Obinutuzumab null N 210027549 AZACITIDINE
210028094 210013772 1.83 null Curative (C) 2018-06-24 2018-06-24 Packer Maintenance Regimen N N 210027676 BR14 TRIAL
210028095 210013773 1.67 60.7 Curative (C) 2019-01-31 2019-02-06 Alemtuzumab + Cyclophos TBI Allo null N 210027899 CARBOPLATIN + ETOPOSIDE + VINCRISTINE
210028096 210013777 1.79 114 null 2017-09-25 2018-01-04 Cyclophosphamide High Dose 2 N 210027966 CYCLOPHOSPHAMIDE + CYTARABINE + ETOPOSIDE + METHOTREXATE + NELARABINE
210028097 210013779 0 68.5 Adjuvant (A) 2018-01-04 2018-01-05 IPILIMUMAB + NIVOLUMAB N N 210027972 CODOX M
210028098 210013780 1.68 61 null 2018-09-27 2018-10-12 Alemtuzumab + Cyclophos TBI Allo N N 210028000 GEMCITABINE + OXALIPLATIN
210028099 210013781 null null Palliative (P) 2014-05-16 2014-08-06 Maintenance Therapy ALL 02 null 210028000 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210028100 210013783 1.72 83.4 Disease modification (D) 2015-01-25 2015-02-18 CISPLATIN + ETOPOSIDE + IFOSFAMIDE 2 N 210028115 CYCLOPHOSPHAMIDE HIGH DOSE
210028101 210013784 1.77 89.5 Disease modification (D) 2016-10-25 2016-10-25 ALL UKALL2003 C: Ph VII Maintenance Y N 210028303 NHL 2003
210028102 210013785 1.7 90.1 Disease modification (D) 2017-01-20 2017-01-20 FLAG N N 210028634 CTD
210028103 210013785 1.77 null Disease modification (D) null 2017-11-29 CNS Medbl Std Risk Maint Cisplatin N N 210028634 IGEV R
210028104 210022613 1.77 85.6 Disease modification (D) 2015-02-07 2015-02-10 STS Rhabdomyosarcoma RMS 2005 IVADo 02 N 210028976 CYTARABINE + RITUXIMAB
210028105 210013795 null 72.4 Curative (C) 2015-02-11 2015-04-22 CLARITY Trial null N 210029014 ALEMTUZUMAB + CYCLO + FLUDARABINE
210028106 210031567 1.7 86.1 Curative (C) 2019-04-13 2019-04-13 PNET 4 HIT-SIOP Maintenance N N 210029239 OFATUMUMAB
210028107 210022615 1.57 34.3 Neo-adjuvant (N) 2018-11-02 2018-11-02 Packer Induction Vincristine + RT Y N 210029261 CYCLO + FLUDARABINE + RITUXIMAB
210028108 210022615 1.57 null Palliative (P) 2019-02-01 2019-02-01 Bortezomib + Cyclophos + Dex N N 210029261 RCEOP
210028109 210028188 1.81 68 Curative (C) 2016-04-16 2016-05-28 Capecitabine null null 210029508 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB
210028110 210013802 null 60.4 Palliative (P) 2016-12-13 2016-12-24 ICE-R null N 210029535 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB
210028111 210013802 1.58 72.6 Curative (C) 2016-08-29 2016-09-04 Cyclophosphamide High Dose 2 N 210029535 UKALL2003
210028112 210028190 1.72 null Palliative (P) 2015-03-27 2015-04-03 Maintenance Therapy ALL N null 210029662 ABVD
210028113 210013807 1.74 34 Disease modification (D) 2015-08-23 2015-08-30 Clofarabine + Cytarabine N null 210029666 BR14 TRIAL
210028114 210022620 1.77 45.3 Curative (C) 2019-06-18 2019-06-18 Cladribine + Rituximab Y N 210029815 GEMCITABINE
210028115 210013810 1.83 64 Curative (C) 2016-09-13 2016-10-18 FCR IV - Cycle 2 onwards N Y 210029888 FLAG
210028116 210013811 1.54 null Curative (C) null 2014-07-22 Ibrutinib + Rituximab N N 210029996 PACKER MAINTENANCE
210028117 210028192 1.63 52.6 null 2018-02-08 2018-02-10 DABRAFENIB + TRAMETINIB N Y 210030012 CARBOPLATIN + PEMETREXED
210028118 210013812 1.78 65 Curative (C) 2016-02-21 2016-02-21 FCR IV - Cycle 2 onwards 2 N 210030019 CLARITY TRIAL
210028119 210022624 1.62 23.5 Curative (C) 2018-05-14 2018-05-28 Packer Maintenance Regimen N N 210030225 NILOTINIB
210028120 210013815 1.68 66 Curative (C) 2017-11-27 2018-01-01 CNS Medbl Std Risk Maint Cisplatin 02 N 210030276 CYTARABINE
210028121 210033711 1.65 63 Palliative (P) 2018-11-08 2019-04-02 Bevacizumab + LOMUSTINE N N 210030452 FLAG
210028122 210028196 1.53 96.1 Disease modification (D) 2018-07-12 2018-08-01 IDARUBICIN Y N 210030490 CLADRIBINE + RITUXIMAB
210028123 210036201 1.63 77 Curative (C) 2018-05-19 2018-05-19 ESHAP 2 N 210030551 IRINOTECAN + MDG
210028124 210013820 null 0 Curative (C) 2014-08-11 2014-08-31 IVE Y N 210030605 PEMBROLIZUMAB
210028125 210013822 1.56 null Disease modification (D) 2017-02-02 2017-02-11 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB N null 210030647 VAI
210028126 210013824 1.66 98 Curative (C) 2017-07-06 2017-08-05 ALL Int Guide B Int Maint Ph III N N 210030823 BR14 TRIAL
210028127 210028198 1.72 null Disease modification (D) 2016-03-19 2016-04-04 Alemtuzumab + Cyclophos TBI Allo N N 210030851 DAUNORUBICIN + VNCRISTINE